Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2026 Jun 4;13(4):e200628. doi: 10.1212/NXI.0000000000200628

Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis

Systematic Review and Meta-Analysis

Nabil K El Ayoubi, Ali Ismail, Georgio Sader, Nour Abi Chakra, Jad El Ahdab, Joseph Abboud, Samia J Khoury
PMCID: PMC13240709  PMID: 42241647

In the Research Article “Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis” by El Ayoubi et al.,1 the number of participants included in the study by Wauschkuhn et al. should be listed as “201” in Table 1, fourth column, final row. The authors regret the error.

Reference

  • 1.El Ayoubi NK, Ismail A, Sader G, et al. Retinal optical coherence tomography longitudinal measures as prognostic biomarkers in multiple sclerosis: systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm. 2025;12(4):e200416. doi: 10.1212/NXI.0000000000200416 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES